Manipulating Ghrelin Signaling Via GOAT Inhibition in Alcohol Use Disorder
Clinical trial NCT03896516 · COMPLETED
Trial details
- NCT number
- NCT03896516
- Sponsor
- National Institute on Drug Abuse (NIDA)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-22
- Primary completion
- 2023-12-04
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.